As an in-home nurse, I get this question almost daily
Notably, only RYGB led to a consistent decrease in postprandial hunger
Popular GLP-1 Options for Weight Loss Over the past several years, GLP-1 receptor agonists have moved from being niche diabetes treatments to some of the most widely discussed weight-loss medications in the world
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes and, in some formulations, to support weight management
New medications such as retatrutide are also being studied and could be next in line for approval
According to the manufacturer's announcement, Novo Nordisk has described a limited-time savings offer for the starting dose at approximately $149 per month, subject to eligibility and change